Related references
Note: Only part of the references are listed.Menstrual cycle regularity as a predictor for heart disease and diabetes: Findings from a large population-based longitudinal cohort study
Sylvia Kiconco et al.
CLINICAL ENDOCRINOLOGY (2022)
Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies
Sylvia Kiconco et al.
CLINICAL ENDOCRINOLOGY (2022)
Dietary carbohydrate and the risk of type 2 diabetes: an updated systematic review and dose-response meta-analysis of prospective cohort studies
Fatemeh Hosseini et al.
SCIENTIFIC REPORTS (2022)
PCOS patients differ in meal timings rather than total caloric or macronutrient intake in comparison to weight matched controls
Bindu Kulshreshtha et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)
Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature
Yalan Xu et al.
JOURNAL OF HEALTHCARE ENGINEERING (2022)
Effects of Dietary Glycemic Index and Glycemic Load on Cardiometabolic and Reproductive Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Maryam Kazemi et al.
ADVANCES IN NUTRITION (2021)
Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: A longitudinal observational study
Young Min Choi et al.
CLINICAL ENDOCRINOLOGY (2021)
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
Christoph Sinning et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study
Ki-Jin Ryu et al.
FERTILITY AND STERILITY (2021)
The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women
Lynn Guo et al.
DIABETES CARE (2021)
Psychiatric disorders as risk factors for type 2 diabetes: An umbrella review of systematic reviews with and without meta-analyses
Nanna Lindekilde et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome
Sofia Persson et al.
FERTILITY AND STERILITY (2021)
Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies
Panagiotis Anagnostis et al.
ENDOCRINE (2021)
Estimates of prediabetes and undiagnosed type 2 diabetes in Denmark: The end of an epidemic or a diagnostic artefact?
Marit Eika Jorgensen et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2020)
Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management
Lisa J. Moran et al.
OBESITY REVIEWS (2020)
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
V Wekker et al.
HUMAN REPRODUCTION UPDATE (2020)
Changes in Metabolic Profile in the Women with a History of PCOS-A Long-Term Follow-Up Study
Malgorzata Jacewicz-Swiecka et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Nadira S. Kakoly et al.
DIABETES CARE (2019)
Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses
Helena Teede et al.
CLINICAL ENDOCRINOLOGY (2019)
Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
Dorte Glintborg et al.
ENDOCRINE CONNECTIONS (2019)
Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study
Noel Yat Hey Ng et al.
PLOS MEDICINE (2019)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Lifestyle changes in women with polycystic ovary syndrome
Siew S. Lim et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Response to Letter to the Editor:Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
Dorte Glintborg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Dorte Glintborg et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews
Chau T. Tay et al.
CLINICAL ENDOCRINOLOGY (2018)
Polycystic ovary syndrome and hyperglycaemia in pregnancy. A narrative review and results from a prospective Danish cohort study
Camilla Viola Buskbjerg Palm et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
Marianne Andersen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede et al.
HUMAN REPRODUCTION (2018)
Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
N. S. Kakoly et al.
HUMAN REPRODUCTION UPDATE (2018)
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS
Dorte Glintborg et al.
ENDOCRINE CONNECTIONS (2018)
Polycystic ovary syndrome and risk factors for gestational diabetes
Sanna Mustaniemi et al.
ENDOCRINE CONNECTIONS (2018)
Prevalence of vitamin D deficiency in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome - A prospective observational study
Krishna Deepti Mogili et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis
F. -F. Wang et al.
OBESITY REVIEWS (2018)
The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Karolina Lagowska et al.
NUTRIENTS (2018)
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Sehar Toosy et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2018)
Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis
Liuting Zeng et al.
ENDOCRINE (2018)
The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis
Vasilios Pergialiotis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
MANAGEMENT OF ENDOCRINE DISEASE Morbidity in polycystic ovary syndrome
Dorte Glintborg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study
M. -M. E. Ollila et al.
HUMAN REPRODUCTION (2017)
The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS
Rasa Pelanis et al.
HUMAN REPRODUCTION (2017)
Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
Katrine Hass Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
Sebastiao Freitas de Medeiros
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2017)
Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
Dorte Glintborg et al.
ENDOCRINE CONNECTIONS (2017)
The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysis
Virginio Salvi et al.
PLOS ONE (2017)
Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance
Anju E. Joham et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls
Dorte Glintborg et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2016)
Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome
Zelija Velija-Asimi et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2016)
A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome
Mohsen Rezaee et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2016)
Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome
David Scott et al.
NUTRIENTS (2016)
Polycystic Ovary Syndrome May Be an Autoimmune Disorder
Hifsa Mobeen et al.
SCIENTIFICA (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2
Neil F. Goodman et al.
ENDOCRINE PRACTICE (2015)
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Daniel A. Dumesic et al.
ENDOCRINE REVIEWS (2015)
Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome
Dorte Glintborg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study
Fahimeh Ramezani Tehrani et al.
PLOS ONE (2015)
Metabolic risk in PCOS: phenotype and adiposity impact
Lisa J. Moran et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Clinical implications of menstrual cycle length in oligomenorrhoeic young women
Jee-Young Oh et al.
CLINICAL ENDOCRINOLOGY (2014)
Global estimates of undiagnosed diabetes in adults
Jessica Beagley et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Gerard Conway et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers
Charikleia Christakou et al.
Hormones-International Journal of Endocrinology and Metabolism (2014)
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mllerian hormone
M. P. Lauritsen et al.
HUMAN REPRODUCTION (2014)
Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome
Dorte Glintborg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study
Hong Yuan Zhang et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Metabolic syndrome in patients with the polycystic ovary syndrome
Dimitrios Panidis et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2013)
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes: Results from a Long-Term Prospective Study
Alessandra Gambineri et al.
DIABETES (2012)
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Evanthia Diamanti-Kandarakis et al.
ENDOCRINE REVIEWS (2012)
Age Associated Differences in Prevalence of Individual Rotterdam Criteria and Metabolic Risk Factors During Reproductive Age in 446 Caucasian Women with Polycystic Ovary Syndrome
D. Glintborg et al.
HORMONE AND METABOLIC RESEARCH (2012)
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
S. S. Lim et al.
HUMAN REPRODUCTION UPDATE (2012)
Prediabetes: a high-risk state for diabetes development
Adam G. Tabak et al.
LANCET (2012)
Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome
Line Velling Magnussen et al.
FERTILITY AND STERILITY (2011)
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
Nese Cinar et al.
HUMAN REPRODUCTION (2011)
Polycystic Ovary Syndrome and Risk for Long-Term Diabetes and Dyslipidemia
Erica T. Wang et al.
OBSTETRICS AND GYNECOLOGY (2011)
Risk of impaired glucose tolerance in normal weight hirsute women during four years observation
Magdalene Andries et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2010)
Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study
Bente Bryhni et al.
BMC ENDOCRINE DISORDERS (2010)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: A randomized study
LC Morin-Papunen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
